MAP Centre for Urban Health Solutions, Unity Health Toronto, Toronto, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Hum Vaccin Immunother. 2021 Dec 2;17(12):5413-5425. doi: 10.1080/21645515.2021.1979379.
Some Canadian jurisdictions offer publicly funded HPV vaccine to gay, bisexual, and other men who have sex with men (GBM) aged ≤26 years. We characterized factors associated with being in different stages of HPV vaccination.
Engage is a sexual health study of GBM in the three largest Canadian cities recruited via respondent driven sampling (RDS). We categorized participants as: (1) unaware of HPV vaccine, (2) undecided/unwilling to get vaccinated, (3) willing to get vaccinated, (4) vaccinated with one or more doses. Our RDS-II weighted analyses used multinomial logistic regression to identify factors associated with being in earlier stages of the cascade compared to Stage 4.
Across the cities, 26-40%, 7-14%, 33-39%, and 13-28% were in Stages 1 to 4, respectively. Compared to Stage 4, being in earlier stages of the cascade was associated with bisexual-identification (Stage 1: adjusted odds ratio[aOR] = 2.84, 95% confidence interval[CI] = 1.06-7.62; Stage 2: aOR = 3.09, 95%CI = 1.19-8.05), having immigrated to Canada (Stage 1: aOR = 1.79, 95%CI 1.07-2.99), preference to keep same-sex romantic relationships private (Stage 1: aOR = 1.25, 95% CI = 1.05-1.48; Stage 2: aOR = 1.24, 95%CI = 1.05-1.46), not receiving sexual health information (Stage 1: aOR = 0.31, 95% CI = 0.13-0.71; Stage 2: aOR = 0.27, 95%CI = 0.12-0.64), not accessing a health-care provider (Stage 2: aOR = 0.36, 95%CI = 0.15-0.83), and no past hepatitis A/B vaccination (Stage 1: aOR = 0.16, 95% CI = 0.09-0.30; Stage 2: aOR = 0.18, 95%CI = 0.09-0.35; Stage 3: aOR = 0.38, 95%CI = 0.21-0.61).
Interventions are needed to reduce social and financial barriers, increase sexual health knowledge, and improve GBM-competent health-care access to increase vaccine uptake among GBM.
一些加拿大司法管辖区为年龄≤26 岁的男同性恋、双性恋和其他与男性发生性关系的男性(GBM)提供公共资助的 HPV 疫苗。我们描述了与处于 HPV 疫苗接种不同阶段相关的因素。
Engage 是一项在加拿大三个最大城市对 GBM 进行的性健康研究,通过受访者驱动抽样(RDS)招募参与者。我们将参与者分为以下几类:(1)不知道 HPV 疫苗,(2)未决定/不愿意接种疫苗,(3)愿意接种疫苗,(4)接种了一剂或多剂疫苗。我们的 RDS-II 加权分析使用多变量逻辑回归来确定与处于疫苗接种级联的早期阶段相比与阶段 4 相关的因素。
在这三个城市中,分别有 26-40%、7-14%、33-39%和 13-28%的参与者处于第 1 到第 4 阶段。与第 4 阶段相比,处于级联的早期阶段与双性恋认同(第 1 阶段:调整后的优势比[aOR]为 2.84,95%置信区间[CI]为 1.06-7.62;第 2 阶段:aOR 为 3.09,95%CI 为 1.19-8.05)、移民到加拿大(第 1 阶段:aOR 为 1.79,95%CI 为 1.07-2.99)、偏好将同性浪漫关系保密(第 1 阶段:aOR 为 1.25,95%CI 为 1.05-1.48;第 2 阶段:aOR 为 1.24,95%CI 为 1.05-1.46)、未接受性健康信息(第 1 阶段:aOR 为 0.31,95%CI 为 0.13-0.71;第 2 阶段:aOR 为 0.27,95%CI 为 0.12-0.64)、未接触卫生保健提供者(第 2 阶段:aOR 为 0.36,95%CI 为 0.15-0.83)和过去未接种甲型肝炎/乙型肝炎疫苗(第 1 阶段:aOR 为 0.16,95%CI 为 0.09-0.30;第 2 阶段:aOR 为 0.18,95%CI 为 0.09-0.35;第 3 阶段:aOR 为 0.38,95%CI 为 0.21-0.61)有关。
需要采取干预措施,减少社会和经济障碍,增加性健康知识,并改善 GBM 合格的医疗保健服务获取途径,以提高 GBM 对疫苗的接种率。